A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial.

Cao, Yu; Wang, Xiaoli; Li, Siqi; Dong, Yuan; Liu, Yonghong; Li, Jing; Zhao, Yanqing; Feng, Yingmei

Cao, Yu; Wang, Xiaoli; Li, Siqi; Dong, Yuan; Liu, Yonghong; Li, Jing; Zhao, Yanqing; Feng, Yingmei.

Cao Y; Department of Science and Technology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Wang X; Beijing Center for Disease Prevention and Control, Beijing, 100013, China.
Li S; Beijing Center for Disease Prevention and Control, Beijing, 100013, China.
Dong Y; Department of Science and Technology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Liu Y; Beijing Center for Disease Prevention and Control, Beijing, 100013, China.
Li J; Sinovac Biotech Co, Ltd, Beijing, Beijing, 100085, China.
Zhao Y; Sinovac Biotech Co, Ltd, Beijing, Beijing, 100085, China.
Feng Y; Department of Science and Technology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. yingmeif13@ccmu.edu.cn.

Sci China Life Sci ; 65(8): 1677-1679, 2022 08.

Article in English | MEDLINE | ID: covidwho-1803053

Subject(s)

COVID-19 Vaccines; COVID-19; Antibodies, Neutralizing; Antibodies, Viral; COVID-19/prevention & control; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Sci China Life Sci Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S11427-022-2110-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google